Clinicians from the Waddell Center for Multiple Sclerosis will conduct MS Symposium 2007: Education, Support and Solutions, a free event for patients, caregivers and health care providers, on Saturday, Oct. 6, at the Oasis Conference Center in Loveland. The Waddell Center is an affiliate of UC Physicians and the Neuroscience Institute at University Hospital and the University of Cincinnati (UC).
After a decade of research, Howard Hughes Medical Institute scientists have succeeded in reprogramming adult stem cells from the testes of male mice into functional blood vessels and contractile cardiac tissue. The research offers a promising new source of stem cells for use in organ regeneration studies.
In a new randomized controlled trial, both aerobic and resistance exercise improved glycemic/blood sugar control in people with type 2 diabetes. The greatest improvements came from combined aerobic and resistance training.
Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive study to date of prescription medications used to treat attention deficit hyperactivity disorder (ADHD) and the potential for increased risk of heart attack, stroke or other cardiovascular problems.
The Food Standards Agency has launched the ”eatwell plate”, a visual tool that illustrates the types and proportions of foods that make up a balanced diet. It updates the previous illustrative model, the ”Balance of Good Health”.
GlaxoSmithKline (NYSE: GSK) believes that conclusions drawn from the most recent meta-analyses published by Drs. Nissen et. al. and Furberg et. al. in the Journal of the American Medical Association (JAMA) do not confirm a difference in the safety profile of Avandia (rosiglitazone) and Actos (pioglitazone).
More than 20 million adults in the United States are living with diabetes and are at increased risk of cardiovascular disease (CVD). But there are steps that they can take to reduce the complications associated with these two diseases.
A child born in the United States in 2005 can expect to live nearly 78 years (77.9) – a new high – according to a report released today by the Centers for Disease Control and Prevention, “Deaths: Preliminary Data for 2005.”
A new book of pocket-charts that will help health workers to identify people at risk of heart attacks and strokes and save lives by prescribing the most appropriate treatment is published by the World Health Organization (WHO).
The U.S. Food and Drug Administration approved Evista (raloxifene hydrochloride) for reducing the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast cancer.